Skip to main content
Clinical Trials/2024-515124-36-00
2024-515124-36-00
Completed
Phase 1

A single-centre, open-label, phase I trial evaluating the pharmacokinetics of single ascending oral doses of IRL757 in healthy elderly volunteers

Integrative Research Laboratories Sweden AB1 site in 1 country12 target enrollmentSeptember 9, 2024

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Integrative Research Laboratories Sweden AB
Enrollment
12
Locations
1
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
euclinicaltrials.eu
Start Date
September 9, 2024
End Date
TBD
Last Updated
last year

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Chief Medical Officer

Scientific

Integrative Research Laboratories Sweden AB

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials